SevenBridge Financial Group LLC Acquires 1,092 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

SevenBridge Financial Group LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 15.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,222 shares of the healthcare conglomerate's stock after acquiring an additional 1,092 shares during the quarter. SevenBridge Financial Group LLC's holdings in UnitedHealth Group were worth $4,390,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently made changes to their positions in the business. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at $25,000. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at $30,000. Promus Capital LLC purchased a new position in UnitedHealth Group in the 4th quarter worth about $32,000. Pillar Financial Advisors LLC purchased a new stake in UnitedHealth Group during the fourth quarter valued at about $40,000. Finally, DecisionPoint Financial LLC increased its position in shares of UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock worth $52,000 after acquiring an additional 62 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock traded up $0.49 on Wednesday, reaching $523.61. The stock had a trading volume of 2,368,702 shares, compared to its average volume of 4,235,187. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The business's 50-day moving average price is $509.15 and its two-hundred day moving average price is $542.83. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market cap of $478.95 billion, a P/E ratio of 33.78, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the prior year, the company earned $5.83 EPS. The firm's revenue for the quarter was up 6.8% compared to the same quarter last year. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. UnitedHealth Group's dividend payout ratio is currently 54.19%.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.33% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the stock. Oppenheimer raised their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. Wells Fargo & Company reduced their price objective on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research note on Tuesday, January 28th. Cantor Fitzgerald reiterated an "overweight" rating and issued a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. HSBC raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective on the stock in a research report on Friday, January 10th. Finally, Truist Financial decreased their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Twenty analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Buy" and an average target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.